Multiple myeloma is a bone marrow cancer in which plasma cells have become cancerous. Plasma cells, a type of white blood cell, are an essential part of the immune system. They make antibodies, a type of protein, that help fight infections.
Hematologist and oncologist Sarah Holstein, MD, PhD, is leading a nationwide study to test the effectiveness of a new placentaderived natural killer (NK) cell therapy.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?